Hyperforin plasma level as a marker of treatment adherence in the national institutes of health hypericum depression trial / Benedetto Vitiello en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 243-249 Título : Hyperforin plasma level as a marker of treatment adherence in the national institutes of health hypericum depression trial Tipo de documento: texto impreso Autores: Benedetto Vitiello, Autor ; Richard I. Shader, Autor ; Corette B. Parker, Autor Fecha de publicación: 2023 Artículo en la página: pp. 243-249 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Institutos Nacionales de Salud (EE. UU.), Floroglucinol, Terpenos. Resumen: A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results. Link: ./index.php?lvl=notice_display&id=30909 [artículo] Hyperforin plasma level as a marker of treatment adherence in the national institutes of health hypericum depression trial [texto impreso] / Benedetto Vitiello, Autor ; Richard I. Shader, Autor ; Corette B. Parker, Autor . - 2023 . - pp. 243-249. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 243-249 Palabras clave: Trastorno depresivo mayor, Institutos Nacionales de Salud (EE. UU.), Floroglucinol, Terpenos. Resumen: A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results. Link: ./index.php?lvl=notice_display&id=30909

---

1 (1 - 1 / 1)